Skip to main content
Log in

Intrapericardial NUT Midline Carcinoma: Unusual Presentation of a Rare Tumor and Literature Review with Management Considerations

  • Case Report
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Rearrangements in the nuclear protein in testis (NUT) gene cause carcinomas that represent a rare but aggressive tumor type that often present at advanced stages in midline structures. Survival rarely exceeds 12 months from the time of diagnosis. There have been no reports of a primary cardiac presentation, and few studies have reported on the numerous treatment strategies. Given their aggressive and invasive nature, NUT midline carcinomas present a therapeutic dilemma. Treatment may include surgical resection, chemotherapy, or radiotherapy, but no consistently successful treatment has been established. Surgical resection is indicated to reduce symptomatic mass effect whenever present. Novel therapies with bromodomain extra-terminal inhibitors may be associated with potential survival benefit. Here, we describe an unusual presentation of this tumor. Literature review with management considerations is underlying.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Ball A, Bromley A, Glaze S, French CA, Ghatage P, Köbel M (2012) A rare case of NUT midline carcinoma. Gynecol Oncol Case Rep 3:1–3

    Article  PubMed Central  PubMed  Google Scholar 

  2. Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Lüer SC, Muhammed S, Evans AG, Sholl LM, Rosai J, Giraldi E, Oakley RP, Rodriguez-Galindo C, London WB, Sallan SE, Bradner JE, French CA (2012) Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 18(20):5773–5779

    Article  PubMed Central  PubMed  Google Scholar 

  3. Evans AG, French CA, Cameron MJ, Fletcher CD, Jackman DM, Lathan CS, Sholl LM (2012) Pathologic characteristics of NUT midline carcinoma arising in the mediastinum. Am J Surg Pathol 36(8):1222–1227

    Article  PubMed Central  PubMed  Google Scholar 

  4. French C (2014) NUT midline carcinoma. Nat Rev Cancer 14(3):149–150

    Article  CAS  PubMed  Google Scholar 

  5. French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA, Nose V, Vargas SO, Moschovi M, Tzortzatou-Stathopoulou F, Miyoshi I, Perez-Atayde AR, Aster JC, Fletcher JA (2004) Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 22(20):4135–4139

    Article  CAS  PubMed  Google Scholar 

  6. Maher OM, Christensen AM, Yedururi S, Bell D, Tarek N (2015) Histone deacetylase inhibitor for NUT midline carcinoma. Pediatr Blood Cancer 62(4):715–717

    Article  PubMed  Google Scholar 

  7. Marx GA, Moran AM (2008) Cardiac Tumors. In: Allen HD, Driscol DJ, Shaddy RE, Feltes TF (eds) Heart disease in infants, children, and adolescents, including the fetus and young adult. Lippincott Williams and Wilkins, Philadelphia, pp 1549–1564

    Google Scholar 

  8. Nakamura H, Tsuta K, Tsuda H, Katsuya Y, Naka G, Iizuka T, Igari T (2015) NUT midline carcinoma of the mediastinum showing two types of poorly differentiated tumor cells: a case report and a literature review. Pathol Res Pract 211(1):92–98

    Article  PubMed  Google Scholar 

  9. Nelson BA, Lee EY, French CA, Bauer DE, Vargas SO (2010) BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings. J Thorac Imaging 25(3):W93–W96

    Article  PubMed  Google Scholar 

  10. Oh SJ, Yeom SY, Kim KH (2013) Clinical implication of surgical resection for the rare cardiac tumors involving heart and great vessels. J Korean Med Sci 28(5):717–724

    Article  PubMed Central  PubMed  Google Scholar 

  11. Padalino MA, Basso C, Milanesi O, Vida VL, Moreolo GS, Thiene G, Stellin G (2005) Surgically treated primary cardiac tumors in early infancy and childhood. J Thorac Cardiovasc Surg 129(6):1358–1363

    Article  PubMed  Google Scholar 

  12. Parikh SA, French CA, Costello BA, Marks RS, Dronca RS, Nerby CL, Roden AC, Peddareddigari VG, Hilton J, Shapiro GI, Molina JR (2013) NUT midline carcinoma: an aggressive intrathoracic neoplasm. J Thorac Oncol 8(10):1335–1338

    Article  PubMed  Google Scholar 

  13. Tensha Therapeutics (2015) Tensha therapeutics: therapeutic program, bromodomain opportunity, TEN-010, clinical program. Tensha Therapeutics. Retrieved 26 July 2015, from http://www.tenshatherapeutics.com/program-ten-010.php

  14. Teo M, Crotty P, O’Sullivan M, French CA, Walshe JM (2011) NUT midline carcinoma in a young woman. J Clin Oncol 29(12):e336–e339

    Article  PubMed  Google Scholar 

  15. Tutak E, Satar M, Ozbarlas N, Uğuz A, Yapicioğlu H, Narli N, Bayram I (2008) A newborn infant with intrapericardial rhabdomyosarcoma: a case report. Turk J Pediatr 50(2):179–181

    PubMed  Google Scholar 

  16. U.S. National Institutes of Health (2015) A two part, multicenter, open-label study of TEN-010 given subcutaneously. U.S. National Institutes of Health. Retrieved 26 July 2015, from https://www.clinicaltrials.gov/ct2/show/NCT01987362

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefani Samples.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Samples, S., Gleditsch, K. & Polimenakos, A. Intrapericardial NUT Midline Carcinoma: Unusual Presentation of a Rare Tumor and Literature Review with Management Considerations. Pediatr Cardiol 37, 208–211 (2016). https://doi.org/10.1007/s00246-015-1313-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-015-1313-3

Keywords

Navigation